Astrocyte Pharmaceuticals
Cambridge
About Astrocyte Pharmaceuticals
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain injury patients. The company is committed to proving the neuroprotective benefits of selective astrocyte activation and advancing breakthrough therapeutic agents for treating brain injury resulting from stroke, TBI, concussion, and neurodegenerative disorders such as Alzheimer’s disease.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $37.2M
- Funding stage: Early Stage Venture
- Last round: Series B (Aug 2023)
- Website: astrocytepharma.com
- Phone: (617)444-8765
Industries & Categories
Biotechnology, Clinical Trials, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/astrocyte-pharmaceuticals-30254 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.